The third quarter of 2022 started positively for the North American Doxycycline Hydrochloride Prices, with prices settling at USD 85320/MT in July. Lack of inventory and high demand for the product from the downstream pharmaceutical industry were the reasons behind the spike. Many Chinese API production facilities were shut down for maintenance during the last week of July, significantly reducing imports into the US. However, these values eventually decreased from the second half of the quarter and were assembled at USD 83890/MT in September. Demand from the downstream sector declined during H2 as downstream entities were in a solid wait-and-see attitude, forcing US suppliers to cut their prices to increase orders.